Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
IMPACT FACTOR
2023
1.5
MNiSW
20
Indexed in:
ESCI

Web of Science
Clarivate Analytics
JCI
0.31

Journal Citation Indicator
CiteScore 2024
3.1
 
NEW Guidelines for Authors!

Clinical and Experimental Hepatology, is the official journal of the Polish Association for Study of Liver.

Indexed in PubMed and Web of Science Core Collection
3/2021
vol. 7
 
 

 
Review article

Overview of lenvatinib as a targeted therapy for advanced hepatocellular carcinoma

Obaid Rehman, Urooj Jaferi, Inderbir Padda, Nimrat Khehra, Harshan Atwal, Dina Mossabeh, Ranvir Bhangu
Clin Exp HEPATOL 2021; 7, 3: 249-257
Online publish date: 2021-10-11
 
DOI : https://doi.org/10.5114/ceh.2021.109312
Original paper

Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long term

Mahmoud Atamla, Johad Khoury, Ihab Dabbah, Rimma Kramsky, Afif Yaacob, Ella Veitsman, Tarek Saadi
Clin Exp HEPATOL 2021; 7, 3: 258-263
Online publish date: 2021-09-20
 
DOI : https://doi.org/10.5114/ceh.2021.109192
Original paper

Effect of abdominal fat distribution on severity of acute pancreatitis

Engin Beydogan, Semih Gulle, Celal Gezer, Banu Boyuk
Clin Exp HEPATOL 2021; 7, 3: 264-269
Online publish date: 2021-10-11
 
DOI : https://doi.org/10.5114/ceh.2021.109345
Original paper

Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification

Maurizio Cesari, Anna Chiara Frigo, Salvatore Piano, Paolo Angeli
Clin Exp HEPATOL 2021; 7, 3: 270-277
Online publish date: 2021-08-23
 
DOI : https://doi.org/10.5114/ceh.2021.108708
Original paper

Evaluation of interleukin 8 polymorphisms (-251T/A and +781C/T) in patients with hepatocellular carcinoma: a meta-analysis

Omid Emami Aleagha, Forouzan Moeinzadeh, Seyedeh Farnaz Moeini Shokouh, Erkan Doğan, Masoud Sadeghi
Clin Exp HEPATOL 2021; 7, 3: 278-285
Online publish date: 2021-10-12
 
DOI : https://doi.org/10.5114/ceh.2021.109424
Original paper

Prevalence and predictors of post-liver transplantation metabolic bone diseases

Maha Elsabaawy, Sameh Afify, Gasser El-Azab, Asmaa Gomaa, Nabil Omar, Mohamed Hashim, Dalia Elsabaawy, Helmy Elshazly
Clin Exp HEPATOL 2021; 7, 3: 286-292
Online publish date: 2021-10-11
 
DOI : https://doi.org/10.5114/ceh.2021.109412
Original paper

Relation between levels of toll-like receptors 3 and 7 and clinical profile of Child-Pugh B cirrhotic patients

Ahmed Kamal, Ahmed Ramadan, Dalia Sherief, Asmaa Hassan, Nahla Nosair, Maaly Mabrouk, Eman Habeeb, Tamer Haydra
Clin Exp HEPATOL 2021; 7, 3: 293-296
Online publish date: 2021-09-21
 
DOI : https://doi.org/10.5114/ceh.2021.109336
Original paper

Liver function test abnormalities in COVID-19 patients and factors affecting them – a retrospective study

Mona Mohammed Abdelrahman, Asmaa A. Abdel-baset, Mustafa Adel Younis, Mahmoud Gaber Mahmoud, Noha Saber Shafik
Clin Exp HEPATOL 2021; 7, 3: 297-304
Online publish date: 2021-09-23
 
DOI : https://doi.org/10.5114/ceh.2021.109225
Original paper

Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis

Adinda Ayu Dyah, Rahadina Rahadina
Clin Exp HEPATOL 2021; 7, 3: 305-311
Online publish date: 2021-09-20
 
DOI : https://doi.org/10.5114/ceh.2021.109228
Original paper

Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study

Tary Salman, Maha Elsabaawy, Mahmoud Omar, Mohamed Afify, Hossam Elezawy, Samar Ghanem, Osama Abdelraouf, Eman Rewisha, Nashwa Shebl
Clin Exp HEPATOL 2021; 7, 3: 312-319
Online publish date: 2021-09-23
 
DOI : https://doi.org/10.5114/ceh.2021.109292
Original paper

Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients

Eman Rewisha, Tary Salman, Omkolsoum Alhaddad, Gamal Abo Raia, Mary Naguib, Shymaa Rashad, Ahmed Abdelfattah, Khaled Metwally, Eman Abdelsameea
Clin Exp HEPATOL 2021; 7, 3: 320-327
Online publish date: 2021-09-22
 
DOI : https://doi.org/10.5114/ceh.2021.109293
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.